Showing posts with label Embryonic Stem Cell. Show all posts
Showing posts with label Embryonic Stem Cell. Show all posts

Saturday, May 2, 2015

Health Research: Light, not pain-killing drugs, used to activate brain's opioid receptors ♦ First embryonic stem cell therapy safety trial ♦ Vital step in stem cell growth revealed

Vitamin D toxicity rare in people who take supplements Americans have low vitamin D levels and as a result vitamin D supplement use has climbed in recent years. Vitamin D has been shown to boost bone health and it may play a role in preventing diabetes, cancer, cardiovascular disease and other illnesses. In light of the increased use of vitamin D supplements, researchers set out to learn more about the health of those with high vitamin D levels. They found that toxic levels are actually rare
First embryonic stem cell therapy safety trial in Asian patients A clinical trial for patients with degenerative eye diseases is the first to test the safety of an embryonic stem cell therapy for people of Asian descent. The study, which followed four individuals for a year after they were treated with embryonic stem cell-derived retinal pigment epithelial cells for macular degeneration, observed no serious side effects related to the therapy.
Light -- not pain-killing drugs -- used to activate brain's opioid receptors Neuroscientists have attached the light-sensing protein rhodopsin to opioid receptor parts to activate the receptor pathways using light from a laser fiber-optic device. When an opioid receptor is exposed to a pain-killing drug, it initiates activity in specific chemical pathways in the brain and spinal cord. And when the researchers shone light on the receptors that contained rhodopsin, the same cellular pathways were activated. Neurons in that part of the brain release chemicals such as dopamine that create feelings of euphoria
Vital step in stem cell growth revealed Stem cells, which have the potential to turn into any kind of cell, offer the tantalizing possibility of generating new tissues for organ replacements, stroke victims and patients of many other diseases. Now, scientist have uncovered details about stem cell growth that could help improve regenerative therapies.

Saturday, January 18, 2014

1/18/14 Health News: Man Suing Grocery Over Tainted Beef Death - New Genetic Risk Factor for Type 2 Diabetics - Embryonic Stem Cell Rejection Fixed

Edmonton man suing grocery chain over tainted-beef death

An Edmonton-area man has launched a $480,000 lawsuit against Save-On-Foods after alleging his wife died as a result of eating E. Coli-tainted beef bought there.According to a statement of claim filed in Court of Queen’s Bench on Jan. 8, Nancy Yauk became “extremely ill” with E. Coli on Oct. 2, 2012, after consuming beef products purchased from Save-On-Foods and died.Continue reading

A Surprising Genetic Risk Factor for Type 2 Diabetes is Discovered
All environmental factors being equal, Mexican Americans and other Latinos are at nearly twice the risk of developing Type 2 diabetes than any other ethnic group. Now, an international research group known as the SIGMA (Slim Initiative in Genomic Medicine for the Americas) Type 2 Diabetes Consortium, may be a step closer to understanding why.  In the largest ever genetic study of its kind conducted a DNA analysis of more than 8,000 residents of Mexico and people who lived in Latin America and discovered a gene variant that highly correlates to developing the disease. People who carry one copy of the variant of this gene, named SLC16A11, have a 25 percent greater risk of developing Type 2 diabetes, while those who inherit the gene variant from both parents -- meaning they have two copies of it -- have a correlating 50 percent risk of developing the disease..Continue Reading

Embryonic Stem Cell Rejection Problem Fixed, Study Says
One of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team. The cells can be made invisible to the immune system by genetically engineering them to make two immune-suppressing molecules..Continue Reading